Literature DB >> 18556461

Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings.

Ali S Arbab1, Branislava Janic, Robert A Knight, Stasia A Anderson, Edyta Pawelczyk, Ali M Rad, Elizabeth J Read, Sunil D Pandit, Joseph A Frank.   

Abstract

This study investigated the factors responsible for migration and homing of magnetically labeled AC133(+) cells at the sites of active angiogenesis in tumor. AC133(+) cells labeled with ferumoxide-protamine sulfate were mixed with either rat glioma or human melanoma cells and implanted in flank of nude mice. An MRI of the tumors including surrounding tissues was performed. Tumor sections were stained for Prussian blue (PB), platelet-derived growth factor (PDGF), hypoxia-inducible factor-1alpha (HIF-1alpha), stromal cell derived factor-1 (SDF-1), matrix metalloproteinase-2 (MMP-2), vascular endothelial growth factor (VEGF), and endothelial markers. Fresh snap-frozen strips from the central and peripheral parts of the tumor were collected for Western blotting. MRIs demonstrated hypointense regions at the periphery of the tumors where the PB(+)/AC133(+) cells were positive for endothelial cells markers. At the sites of PB(+)/AC133(+) cells, both HIF-1alpha and SDF-1 were strongly positive and PDGF and MMP-2 showed generalized expression in the tumor and surrounding tissues. There was no significant association of PB(+)/AC133(+) cell localization and VEGF expression in tumor cells. Western blot demonstrated strong expression of the SDF-1, MMP-2, and PDGF at the peripheral parts of the tumors. HIF-1alpha was expressed at both the periphery and central parts of the tumor. This work demonstrates that magnetically labeled cells can be used as probes for MRI and histological identification of administered cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556461      PMCID: PMC2518252          DOI: 10.1096/fj.07-105676

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  53 in total

1.  Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.

Authors:  T Murohara; H Ikeda; J Duan; S Shintani; K i Sasaki; H Eguchi; I Onitsuka; K Matsui; T Imaizumi
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells.

Authors:  M Gill; S Dias; K Hattori; M L Rivera; D Hicklin; L Witte; L Girardi; R Yurt; H Himel; S Rafii
Journal:  Circ Res       Date:  2001-02-02       Impact factor: 17.367

3.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells.

Authors:  U M Gehling; S Ergün; U Schumacher; C Wagener; K Pantel; M Otte; G Schuch; P Schafhausen; T Mende; N Kilic; K Kluge; B Schäfer; D K Hossfeld; W Fiedler
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

4.  Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1.

Authors:  D Y Jo; S Rafii; T Hamada; M A Moore
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

5.  Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.

Authors:  D Lyden; K Hattori; S Dias; C Costa; P Blaikie; L Butros; A Chadburn; B Heissig; W Marks; L Witte; Y Wu; D Hicklin; Z Zhu; N R Hackett; R G Crystal; M A Moore; K A Hajjar; K Manova; R Benezra; S Rafii
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

Review 6.  Angiogenesis: new insights and therapeutic potential.

Authors:  R J Tomanek; G C Schatteman
Journal:  Anat Rec       Date:  2000-06-15

Review 7.  Overview of angiogenesis: Biologic implications for antiangiogenic therapy.

Authors:  L M Ellis; W Liu; S A Ahmad; F Fan; Y D Jung; R M Shaheen; N Reinmuth
Journal:  Semin Oncol       Date:  2001-10       Impact factor: 4.929

Review 8.  Angiogenesis: regulators and clinical applications.

Authors:  S Liekens; E De Clercq; J Neyts
Journal:  Biochem Pharmacol       Date:  2001-02-01       Impact factor: 5.858

9.  Augmentation of postnatal neovascularization with autologous bone marrow transplantation.

Authors:  S Shintani; T Murohara; H Ikeda; T Ueno; K Sasaki ; J Duan; T Imaizumi
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

10.  In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy.

Authors:  Edyta Pawelczyk; Ali S Arbab; Aneeka Chaudhry; Arun Balakumaran; Pamela G Robey; Joseph A Frank
Journal:  Stem Cells       Date:  2008-02-14       Impact factor: 6.277

View more
  40 in total

1.  Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice.

Authors:  Chiyo Doi; Dharmendra Kumar Maurya; Marla M Pyle; Deryl Troyer; Masaaki Tamura
Journal:  Cytotherapy       Date:  2010-05       Impact factor: 5.414

2.  The expression of P2X₇ receptors in EPCs and their potential role in the targeting of EPCs to brain gliomas.

Authors:  Jingqin Fang; Xiao Chen; Shunan Wang; Tian Xie; Xuesong Du; Heng Liu; Sumei Wang; Xue Li; Jinhua Chen; Bo Zhang; Huaping Liang; Yizeng Yang; Weiguo Zhang
Journal:  Cancer Biol Ther       Date:  2015-04-03       Impact factor: 4.742

3.  20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo.

Authors:  Li Chen; Rachel Ackerman; Mohamed Saleh; Katherine H Gotlinger; Michael Kessler; Lawrence G Mendelowitz; John R Falck; Ali S Arbab; A Guillermo Scicli; Michal L Schwartzman; Jing Yang; Austin M Guo
Journal:  J Pharmacol Exp Ther       Date:  2014-01-08       Impact factor: 4.030

4.  Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging.

Authors:  Karen C Briley-Saebo; Marylene Leboeuf; Stephen Dickson; Venkatesh Mani; Zahi A Fayad; A Karolina Palucka; Jacques Banchereau; Miriam Merad
Journal:  Magn Reson Med       Date:  2010-11       Impact factor: 4.668

5.  Cord blood endothelial progenitor cells as therapeutic and imaging probes.

Authors:  Branislava Janic; Ali S Arbab
Journal:  Imaging Med       Date:  2012-08-01

Review 6.  The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization.

Authors:  Branislava Janic; Ali S Arbab
Journal:  ScientificWorldJournal       Date:  2010-06-15

7.  Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells.

Authors:  Xinying Wu; Yanbin Tan; Hui Mao; Minming Zhang
Journal:  Int J Nanomedicine       Date:  2010-08-09

8.  Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma.

Authors:  Meser M Ali; Branislava Janic; Abbas Babajani-Feremi; Nadimpalli R S Varma; A S M Iskander; John Anagli; Ali S Arbab
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

9.  Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion.

Authors:  Branislava Janic; Austin M Guo; A S M Iskander; Nadimpalli Ravi S Varma; Alfonso G Scicli; Ali S Arbab
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

10.  Therapy with un-engineered naïve rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma.

Authors:  Dharmendra K Maurya; Chiyo Doi; Atsushi Kawabata; Marla M Pyle; Clay King; Zhihong Wu; Deryl Troyer; Masaaki Tamura
Journal:  BMC Cancer       Date:  2010-10-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.